Pharma Intelligence is part of the Business Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
22 Total results for product and free and sample content found
RxScorecard
17 Aug 2017
See how the value of drugs differentiate therapies by sub-population. Find out where the disproportionate value of your drug lies alongside competitors. Uncover demonstrable differentiated value when entering a crowded market. Discover the power of RxScorecard™.
Topic Reimbursement
Pink Sheet
By Cathy Kelly 10 Aug 2017
Four contracts test approaches tying reimbursement to relapse rates and discontinuation of treatment.
Topic Reimbursement
Datamonitor Healthcare
By Tijana Ignjatovik 09 Jun 2017
Informa's Japanese office, a British company that operates Pharma Intelligence, held a special free seminar in Tokyo on May 17, 2017.
Topic Reimbursement
Datamonitor Healthcare
08 Jun 2017
Market Access & Reimbursement: Inside the Payer Perspective on Multiple Myeloma
Topic Reimbursement
Pink Sheet
By Cathy Kelly 12 May 2017
Draft report concludes that added cost of abuse-deterrent opioids is not outweighed by reductions to health care system costs resulting from their use.
Topic Reimbursement
Scrip
By Emily Hayes 02 May 2017
Fast US approval of ultra-rare pediatric disease drug Brineura (cerliponase alfa), with an annual list price of $702,000, is a victory for the company, but approval for restricted pediatric population compared to Europe raised questions.
Topic Rare Disease Reimbursement
Medtech Insight
18 Apr 2017
Five Emory University-affiliated hospitals taking part in a Philips eICU program cut total costs by $4.6m – or $1,468 per average care episode – reduced discharges to nursing homes by 6.9%, and lowered inpatient readmission rates, according to a recent audit by CMS contractors.
Topic Reimbursement
Pink Sheet
By Ian Schofield 12 Apr 2017
Samsung Bioepis’s Brenzys has become the second biosimilar product to be reimbursed as substitutable at the pharmacy level in Australia.
Topic Reimbursement
Pink Sheet
By Cathy Kelly 21 Mar 2017
President's pledge to merge drug pricing control with a revamp of the Affordable Care Act wins applause at Kentucky rally, where the president reeled through a number of his populist issues, even as the idea makes scant legislative progress.
No Records Found
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
How can we help you?
Our team is always happy to hear from you. Please call us at:
Report store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
